S100A7 and ductal breast carcinoma in situ: Consistently, other studies also showed that S100A7 expression was relatively low in normal, benign and atypical hyperplastic proliferative ductal lesions, high in the pre-invasive ductal carcinoma in situ (DCIS), but reduced in invasive carcinomas [25–28].